Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for Statin Immuno-Metabolomics in Asthma (part IV) (Study ST000846)

Reversed phase NEGATIVE ION MODE (Analysis AN001369)

Metabolite	Structure	F1	F2	F3	F4	F5	F6
5_15-DiHETE	ME224570	1.12	0.51	2.98	0.56	0.24	0.59
5-HETE	ME224593	1.80	0.63	0.96	0.47	0.99	1.16
PGE1	ME224561	2.26	0.48	0.94	0.33	0.68	1.31
15-Keto PGE2	ME224563	2.32	0.39	0.83	0.28	1.08	1.10
TXB2	ME224560	2.29	0.36	1.00	0.28	1.18	0.89
5-HEPE	ME224597	2.06	0.91	0.89	0.81	0.58	0.76
PGE3	ME224617	2.56	0.85	1.40	0.62	0.21	0.37
PGE2	ME224562	2.47	0.67	1.25	0.39	0.46	0.75
15-deoxy PGJ2	ME224565	2.51	0.46	1.45	0.17	0.63	0.80
6-keto PGF1a	ME224559	2.36	0.51	1.24	0.30	0.60	0.99
4-HDoHE	ME224600	0.93	0.70	0.57	0.38	1.56	1.86
8(9)-EpETrE	ME224610	0.82	0.64	1.05	0.52	1.68	1.28
20-HETE	ME224588	1.84	1.74	1.35	0.84	0.16	0.08
12(13)-Ep-9-KODE	ME224604	0.70	0.92	0.77	0.89	0.75	1.98
10-Nitrooleate	ME224616	0.87	0.93	0.98	1.32	0.75	1.15
17-HDoHE	ME224598	0.82	1.19	1.06	0.85	0.91	1.17
15_16-DiHODE	ME224576	0.81	1.04	0.87	0.81	0.86	1.62
13-KODE	ME224612	0.66	0.91	0.96	1.14	0.83	1.50
9-KODE	ME224613	0.69	1.08	0.97	0.91	0.84	1.51
12_13-DiHOME	ME224574	0.65	1.12	1.00	1.09	0.69	1.44
9-HODE	ME224585	0.66	1.07	0.93	1.04	0.74	1.57
13-HODE	ME224584	0.56	1.32	1.41	1.43	0.37	0.90
13-HOTE	ME224586	0.47	1.39	1.11	1.46	0.39	1.18
12(13)-EpODE	ME224606	0.64	1.63	0.70	1.51	0.61	0.91
9-HOTE	ME224587	0.44	1.56	0.66	1.47	0.80	1.06
15(16)-EpODE	ME224605	0.50	1.55	0.67	1.22	0.55	1.50
9_10-DiHODE	ME224577	0.53	1.41	0.88	1.26	0.45	1.46
9_10-DiHOME	ME224575	0.59	1.39	1.02	1.16	0.63	1.22
9(10)-EpODE	ME224607	0.69	1.11	0.84	1.35	0.69	1.33
12(13)-EpOME	ME224602	0.62	1.40	0.68	1.34	0.72	1.23
9(10)-EpOME	ME224603	0.65	1.35	0.80	1.30	0.73	1.17
19(20)-EpDPE	ME224611	0.84	1.44	0.85	0.51	1.33	1.02
5-KETE	ME224615	1.17	0.83	1.01	0.60	1.17	1.22
11(12)-EpETrE	ME224609	1.26	0.93	1.38	0.80	0.95	0.69
14(15)-EpETrE	ME224608	1.36	0.90	1.19	0.66	1.02	0.87
15-KETE	ME224614	1.07	0.95	1.28	0.71	1.05	0.93
9-HEPE	ME224596	1.61	1.28	1.71	0.87	0.12	0.41
9-HETE	ME224591	1.35	1.12	1.69	0.89	0.40	0.55
8-HETE	ME224592	1.62	0.86	1.63	0.78	0.44	0.69
Lipoxin A4	ME224568	1.43	0.97	1.60	0.76	0.42	0.81
PGD2	ME224564	1.94	0.67	1.67	0.73	0.32	0.67
11-HETE	ME224567	1.75	0.81	1.47	0.61	0.58	0.78
PGF2a	ME224566	1.74	0.81	1.53	0.48	0.70	0.73
9_10-e-DiHO	ME224573	0.86	0.98	1.88	0.89	0.38	1.01
17_18-DiHETE	ME224582	0.69	0.99	1.53	0.81	0.68	1.30
9_12_13-TriHOME	ME224572	0.77	0.86	1.40	0.96	0.73	1.27
8_15-DiHETE	ME224571	0.97	1.22	1.83	1.25	0.20	0.53
12-HEPE	ME224595	1.06	1.59	1.61	1.15	0.16	0.43
15-HEPE	ME224594	0.97	1.57	1.75	1.02	0.25	0.44
19_20-DiHDoPA	ME224583	1.10	1.58	1.09	1.22	0.42	0.60
8_9-DiHETrE	ME224580	1.08	1.60	1.32	1.00	0.46	0.53
6-trans-LTB4	ME224569	1.11	1.04	1.53	0.93	0.43	0.95
9_10-EpO	ME224601	1.01	1.19	1.47	0.82	0.51	1.00
15-HETE	ME224589	1.28	1.03	1.46	0.93	0.58	0.72
12-HETE	ME224590	1.15	1.20	1.59	0.99	0.38	0.69
5_6-DiHETrE	ME224581	1.00	1.28	1.54	0.92	0.56	0.70
11_12-DiHETrE	ME224579	1.08	1.40	1.05	1.05	0.64	0.77
14_15-DiHETrE	ME224578	1.16	1.23	1.29	1.07	0.48	0.77
14-HDoHE	ME224599	0.87	1.29	1.34	1.07	0.52	0.91

Factors:

F1	Tissue:Left Lung \| Treatment:Control
F2	Tissue:Left Lung \| Treatment:Simvastatin
F3	Tissue:Right Lung \| Treatment:Control
F4	Tissue:Right Lung \| Treatment:Simvastatin
F5	Tissue:Trachea \| Treatment:Control
F6	Tissue:Trachea \| Treatment:Simvastatin

Data matrix